FDA warns Happy Sprout Inc. over insanitary sprout production and Listeria environmental contamination.
What happened
The FDA inspected Happy Sprout Inc.'s sprouting operation in Springfield, Virginia, from May 23-26, 2022, and on July 8, 2022, and found serious violations of the Produce Safety Regulation. Seven environmental swabs collected during the inspection were positive for Listeria species (not Listeria monocytogenes), and a finished product sample collected from a retail location also found Listeria species. FDA also said the firm had not established a written environmental monitoring plan and had not tested the sprout growing, harvesting, packing, and holding environment for Listeria species or Listeria monocytogenes since October 2021.
What FDA found
The firm did not establish and implement a written environmental monitoring plan to identify Listeria species or Listeria monocytogenes in the sprout environment.
21 CFR 112.145The firm did not establish and implement a written sampling plan to test spent sprout irrigation water or in-process sprouts for pathogens such as E. coli O157:H7 or Salmonella.
21 CFR 112.147 and 21 CFR 112.144(b)The firm did not sanitize food contact surfaces before they contacted sprouts or seeds and beans used to grow sprouts.
21 CFR 112.143(b)The firm did not train personnel who handle covered produce or food contact surfaces, and did not ensure supervisor training met the rule, with employees reportedly trained about ten years earlier.
21 CFR 112.21 and 21 CFR 112.22Employees did not use hygienic practices, including handwashing before donning gloves, changing soiled gloves, and avoiding jewelry while packaging sprouts.
21 CFR 112.32The mung bean and soybean sprout products were adulterated because they were prepared, packed, or held under insanitary conditions.
Federal Food, Drug, and Cosmetic Act section 402(a)(4) [21 U.S.C. § 342(a)(4)]
What FDA wants
FDA asks Happy Sprout to respond in writing within 15 working days of receiving the letter with the specific steps taken, related documentation, and steps to prevent recurrence; if corrective action cannot be completed in that time, the firm must state why and when it will be done.
Who should pay attention
- retailers and consumers of raw sprouts
- brands that source sprouts from this firm
- other sprout growers managing environmental monitoring and sanitation
This is a summary. Read the original letter on fda.gov.